InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（36 笔）
内部人交易记录
首席执行官已披露买入
0
已披露卖出
36
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the complete record of transactions filed by Goldsmith Mark A, 管理人员. Insider active across 2 companies, notably Revolution Medicines, Inc.. Cumulatively, 65 filings have been logged. Breakdown: 0 buy · 36 sells. Total volume traded: €36.5m. History available since 17 June 2021. The latest transaction was filed on 21 August 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Goldsmith Mark A
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报65 总计
80,000 股@ US$4.73Common StockSEC:0001610717-26-000387:0
5,128 股@ US$207.233Common StockSEC:0001610717-26-000387:1
24,917 股@ US$208.3697Common StockSEC:0001610717-26-000387:2
35,938 股@ US$209.2615Common StockSEC:0001610717-26-000387:3
3,813 股@ US$210.2466Common StockSEC:0001610717-26-000387:4
6,583 股@ US$211.3331Common StockSEC:0001610717-26-000387:5
3,621 股@ US$212.0776Common StockSEC:0001610717-26-000387:6
190 股@ US$207.2454Common StockSEC:0001610717-26-000387:7
951 股@ US$208.3648Common StockSEC:0001610717-26-000387:8
1,351 股@ US$209.2812Common StockSEC:0001610717-26-000387:9
136 股@ US$210.4017Common StockSEC:0001610717-26-000387:10
245 股@ US$211.4651Common StockSEC:0001610717-26-000387:11
127 股@ US$212.0635Common StockSEC:0001610717-26-000387:12
177 股@ US$207.2515Common StockSEC:0001610717-26-000387:13
937 股@ US$208.3609Common StockSEC:0001610717-26-000387:14
1,405 股@ US$209.2664Common StockSEC:0001610717-26-000387:15
126 股@ US$210.403Common StockSEC:0001610717-26-000387:16
229 股@ US$211.4648Common StockSEC:0001610717-26-000387:17
126 股@ US$212.0641Common StockSEC:0001610717-26-000387:18
10,020 股Common StockSEC:0001610717-26-000246:0
23,244 股@ US$4.090.4% 占其流量Common StockSEC:0001610717-26-000146:0
96,756 股@ US$4.732.0% 占其流量Common StockSEC:0001610717-26-000146:1
120,000 股@ US$150.087480.0% 占其流量Common StockSEC:0001610717-26-000146:2
12,871 股@ US$99.48045.4% 占其流量Common StockSEC:0001610717-26-000130:0
57,100 股0Common StockSEC:0001610717-26-000082:0
65 条申报中的 25 条
About Goldsmith Mark A
GOLDSMITH MARK A is an insider linked to Revolution Medicines, Inc. and, according to the data provided, also a director at Constellation Pharmaceuticals INC. Across 46 filings in total, the sampled recent filings from 2021-06-22 to 2026-06-18 show 0 in buys and 21139829 in sells, with the modal transaction nature listed as option exercise.
